Literature DB >> 20397952

HIV infection-related tuberculosis: clinical manifestations and treatment.

Timothy R Sterling1, Paul A Pham, Richard E Chaisson.   

Abstract

Several aspects of human immunodeficiency virus (HIV) infection-related tuberculosis (TB) and its treatment differ from those of TB in HIV-uninfected persons. The risk of TB and the clinical and radiographic manifestations of disease are primary examples. Antiretroviral therapy has a profound effect on lowering the risk of TB in HIV-infected persons, but it can also be associated with immune reconstitution inflammatory disease and unmasking of previously subclinical disease. There are also differences in treatment of HIV infection-related TB because of overlapping drug toxicities and drug-drug interactions between antiretroviral therapy and anti-TB therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20397952     DOI: 10.1086/651495

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Pulmonary TB: varying radiological presentations in individuals with HIV in Soweto, South Africa.

Authors:  Jesne Kistan; Fatima Laher; Kennedy Otwombe; Ravindre Panchia; Nohemie Mawaka; Limakatso Lebina; Andreas Diacon; Bavesh Kana; Neil Martinson
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-03-01       Impact factor: 2.184

2.  Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Authors:  Diane V Havlir; Michelle A Kendall; Prudence Ive; Johnstone Kumwenda; Susan Swindells; Sarojini S Qasba; Anne F Luetkemeyer; Evelyn Hogg; James F Rooney; Xingye Wu; Mina C Hosseinipour; Umesh Lalloo; Valdilea G Veloso; Fatuma F Some; N Kumarasamy; Nesri Padayatchi; Breno R Santos; Stewart Reid; James Hakim; Lerato Mohapi; Peter Mugyenyi; Jorge Sanchez; Javier R Lama; Jean W Pape; Alejandro Sanchez; Aida Asmelash; Evans Moko; Fred Sawe; Janet Andersen; Ian Sanne
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

Review 3.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

4.  Immunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients.

Authors:  S Danaviah; J A Sacks; K P S Kumar; L M Taylor; D A Fallows; T Naicker; T Ndung'u; S Govender; G Kaplan
Journal:  Tuberculosis (Edinb)       Date:  2013-03-28       Impact factor: 3.131

Review 5.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 6.  Spinal tuberculosis: a review.

Authors:  Ravindra Kumar Garg; Dilip Singh Somvanshi
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

7.  Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi.

Authors:  Kashmira S Chawla; Cecilia Kanyama; Abineli Mbewe; Mitch Matoga; Irving Hoffman; Jonathan Ngoma; Mina C Hosseinipour
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

8.  Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.

Authors:  Nagsen Gautam; Upal Roy; Shantanu Balkundi; Pavan Puligujja; Dongwei Guo; Nathan Smith; Xin-Ming Liu; Benjamin Lamberty; Brenda Morsey; Howard S Fox; Joellyn McMillan; Howard E Gendelman; Yazen Alnouti
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

9.  Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection.

Authors:  Jeong-Hwan Hwang; Pyoeng Gyun Choe; Nak Hyun Kim; Ji Hwan Bang; Kyoung-Ho Song; Wan Beom Park; Eu Suk Kim; Sang Won Park; Hong-Bin Kim; Nam Joong Kim; Myoung-Don Oh; Kang Won Choe
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

Review 10.  Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.

Authors:  Kerry L Dierberg; Richard E Chaisson
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.